These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37773752)

  • 1. Identifying essential long non-coding RNAs in cancer using CRISPRi-based dropout screens.
    Bril O; Schwarzmueller LJ; Moreno LF; Vermeulen L; Léveillé N
    STAR Protoc; 2023 Dec; 4(4):102588. PubMed ID: 37773752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing libraries for pooled CRISPR functional screens of long noncoding RNAs.
    Pulido-Quetglas C; Johnson R
    Mamm Genome; 2022 Jun; 33(2):312-327. PubMed ID: 34533605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network.
    Morelli E; Gulla' A; Amodio N; Taiana E; Neri A; Fulciniti M; Munshi NC
    Methods Mol Biol; 2021; 2348():189-204. PubMed ID: 34160808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter integrated analysis of noncoding CRISPRi screens.
    Yao D; Tycko J; Oh JW; Bounds LR; Gosai SJ; Lataniotis L; Mackay-Smith A; Doughty BR; Gabdank I; Schmidt H; Guerrero-Altamirano T; Siklenka K; Guo K; White AD; Youngworth I; Andreeva K; Ren X; Barrera A; Luo Y; Yardımcı GG; Tewhey R; Kundaje A; Greenleaf WJ; Sabeti PC; Leslie C; Pritykin Y; Moore JE; Beer MA; Gersbach CA; Reddy TE; Shen Y; Engreitz JM; Bassik MC; Reilly SK
    Nat Methods; 2024 Apr; 21(4):723-734. PubMed ID: 38504114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning the Expression of Long Noncoding RNA Loci with CRISPR Interference.
    Stojic L
    Methods Mol Biol; 2020; 2161():1-16. PubMed ID: 32681501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs.
    Aparicio-Prat E; Arnan C; Sala I; Bosch N; Guigó R; Johnson R
    BMC Genomics; 2015 Oct; 16():846. PubMed ID: 26493208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
    Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
    Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements.
    Tycko J; Wainberg M; Marinov GK; Ursu O; Hess GT; Ego BK; Aradhana ; Li A; Truong A; Trevino AE; Spees K; Yao D; Kaplow IM; Greenside PG; Morgens DW; Phanstiel DH; Snyder MP; Bintu L; Greenleaf WJ; Kundaje A; Bassik MC
    Nat Commun; 2019 Sep; 10(1):4063. PubMed ID: 31492858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-regulated lncRNA discovery enhanced by in vivo identification and CRISPRi functional validation.
    Liu S; Harmston N; Glaser TL; Wong Y; Zhong Z; Madan B; Virshup DM; Petretto E
    Genome Med; 2020 Oct; 12(1):89. PubMed ID: 33092630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CASPR, an analysis pipeline for single and paired guide RNA CRISPR screens, reveals optimal target selection for long non-coding RNAs.
    Bergadà-Pijuan J; Pulido-Quetglas C; Vancura A; Johnson R
    Bioinformatics; 2020 Mar; 36(6):1673-1680. PubMed ID: 31681950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
    Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
    Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.
    Hart T; Tong AHY; Chan K; Van Leeuwen J; Seetharaman A; Aregger M; Chandrashekhar M; Hustedt N; Seth S; Noonan A; Habsid A; Sizova O; Nedyalkova L; Climie R; Tworzyanski L; Lawson K; Sartori MA; Alibeh S; Tieu D; Masud S; Mero P; Weiss A; Brown KR; Usaj M; Billmann M; Rahman M; Constanzo M; Myers CL; Andrews BJ; Boone C; Durocher D; Moffat J
    G3 (Bethesda); 2017 Aug; 7(8):2719-2727. PubMed ID: 28655737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference.
    Ghosh S; Tibbit C; Liu JL
    Nucleic Acids Res; 2016 May; 44(9):e84. PubMed ID: 26850642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
    Esposito R; Bosch N; Lanzós A; Polidori T; Pulido-Quetglas C; Johnson R
    Cancer Cell; 2019 Apr; 35(4):545-557. PubMed ID: 30827888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-coding RNAs and CRISPR-Cas Edition in Tumorigenesis.
    Furtado CLM; da Silva Santos R; Sales SLA; Teixeira LPR; Pessoa CDÓ
    Adv Exp Med Biol; 2023; 1429():41-58. PubMed ID: 37486515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational pipeline for designing guide RNAs for mismatch-CRISPRi.
    van Gestel J; Hawkins JS; Todor H; Gross CA
    STAR Protoc; 2021 Jun; 2(2):100521. PubMed ID: 34027480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Based Gene Dropout Screens.
    Wu K; Malek SN
    Methods Mol Biol; 2019; 1881():185-200. PubMed ID: 30350207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Scale Perturbation of Long Noncoding RNA Expression Using CRISPR Interference.
    Liu SJ; Horlbeck MA; Weissman JS; Lim DA
    Methods Mol Biol; 2021; 2254():323-338. PubMed ID: 33326085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models.
    Attenello FJ; Tsung K; Bishara I; Loh YE; Chen TC
    J Neurosci Res; 2021 Sep; 99(9):2029-2045. PubMed ID: 33969526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.